• 1
    Porter J, Canaday WR Jr. Hematologic values in mongrel and Greyhound dogs being screened for research use. J Am Vet Med Assoc 1971;159:16031606.
  • 2
    Sullivan PS, Evans HL, McDonald TP. Platelet concentration and hemoglobin function in Greyhounds. J Am Vet Med Assoc 1994;205:838841.
  • 3
    Steiss JE, Brewer WG, Welles E, Wright JC. Hematologic and serum biochemical reference values in retired Greyhounds. Compend Cont Educ 2000;22:243248.
  • 4
    Fayos M, Couto CG, Cline Iazbik MC, Wellman M. Serum protein electrophoresis in retired racing Greyhounds. Vet Clin Pathol 2005;34:397400.
  • 5
    Couto CG, Lara A, Iazbik MC, Brooks M. Evaluation of platelet aggregation using a point-of-care instrument in retired racing Greyhounds. J Vet Intern Med 2006;20:365370.
  • 6
    Lord L, Jaissle J, Marin L, Couto CG. Results of a web-based health survey of retired racing greyhounds. J Vet Intern Med 2007;21:12431250.
  • 7
    Adams GL, Manson RJ, Turner I, et al. The balance of thrombosis and hemorrhage in surgery. Hematol Oncol Clin N Am 2007;21:1327.
  • 8
    Hoffman M, Monroe DM. Coagulation 2006: A modern view of hemostasis. Hematol Oncol Clin N Am 2007;21:111.
  • 9
    Moake JL. Mechanisms of disease: Thrombotic microangiopathies. N Eng J Med 2000;347:589600.
  • 10
    Martin JN, Rose CH, Briery CM. Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195:914934.
  • 11
    Buchanan GR, Adix L. Grading for hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002;141:683688.
  • 12
    Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer PFA-100. Semin Throm Haemost 1995;21 (Suppl 2):106112.
  • 13
    Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195202.
  • 14
    Iazbik MC, Couto CG, Gray TL, Kociba G. Hemostatic evaluation of canine plasma collected for transfusion and stored under different conditions. Am J Vet Res 2001;62:734735.
  • 15
    Otto CM, Rieser TM, Brooks MB, et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2005;10:15001504.
  • 16
    Benson RE, Catalfamo JL, Brooks M, Dodds WJ. A sensitive immunoassay for von Willebrand factor. J Immunoassay 1991;12:371390.
  • 17
    Sabino EP, Erb HN, Catalfamo JL. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs. Am J Vet Res 2006;67:242249.
  • 18
    Favaloro EJ. Collagen binding assay for von Willebrand factor (VWF:CBA): Detection of von Willebrands disease (VWD), and discrimination of VWD subtypes, depends on collagen source. Thromb Haemost 2000;83:127135.
  • 19
    Lanevschi A, Kramer JW, Greene SA, Meyers KM. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs. Am J Vet Res 1996;57:11241130.
  • 20
    Stokol T, Brooks MB, Erb HN, Mauldin GE d-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation. Am J Vet Res 2000;61:393398.
  • 21
    Triplett DA, Harms CS. Factor XIII deficiency screen. In: TriplettDA, ed. Procedures for the Coagulation Laboratory. Chicago, IL: Educational Products Division; 1981:6768.
  • 22
    Lorand L. Sol Sherry lecture in thrombosis: Research on clot stabilization provides clues for improving thrombolytic therapies. Arterioscler Thromb Vasc Biol 2000;20:29.
  • 23
    Barr SC, Ludders JW, Looney AL, et al. Platelet aggregation in dogs after sedation with acepromazine and atropine and during subsequent general anesthesia and surgery. Am J Vet Res 1992;53:20672070.
  • 24
    Bergmann HM, Nolte IJ, Kramer S. Effects of preoperative administration of carprofen on renal function and hemostasis in dogs undergoing surgery for fracture repair. Am J Vet Res 2005;66:13561363.
  • 25
    Gaal T, Halmay D, Kocsis R, Abonyi-Toth Z. Evaluation of the effect of ketoprofen and carprofen on platelet function in dogs studied by PFA-100 point-of-care analyser. Acta Vet Hung 2007;55:287294.
  • 26
    Brooks M. Von Willebrand disease. In: FeldmanBF, ZinklJG, JainNC, eds. Schalm's Veterinary Hematology, 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:509515.
  • 27
    Fabrizio F, Baumwart R, Cline MC, et al. Functional systolic murmur in retired racing Greyhounds. J Vet Intern Med 2006;20:7882.
  • 28
    Tarnow I, Kristensen AM, Olsen LH, et al. Dogs with heart diseases causing turbulent high-velocity blood flow have changes in platelet function and von Willebrand multimer distribution. J Vet Intern Med 2005;19:515522.
  • 29
    Blann AD, Naqvi T, Waite M, McCollum CN. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993;7:107111.
  • 30
    Cox RX, Peterson LH, Detweiler DK. Comparison of arterial hemodynamics in the mongrel dog and the racing Greyhound. Am J Physiol 1976;230:211218.
  • 31
    Couto CG, Iazbik MC. Effects of blood donation on arterial pressure in retired racing Greyhounds. J Vet Intern Med 2005;19:845848.
  • 32
    Agren A, Wiman B, Schulman S. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Blood Coagul Fibrinolysis 2007;18:657660.
  • 33
    Hu KO, Yu AS, Tiyyagura L, et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol 2001;96:15811586.
    Direct Link:
  • 34
    Ross J, Dallap BL, Dolente BA, Sweeney RW. Pharmacokinetics and pharmacodynamics of ɛ-amicocaproic acid in horses. Am J Vet Res 2007;68:10161021.
  • 35
    Millis DL, Hauptman JG, Richter M. Preoperative and postoperative hemostatic profiles of dogs undergoing ovariohysterectomy. Cornell Vet 1992;82:465470.
  • 36
    Siemens HJ, Brueckner S, Hagekberg S, et al. Course of molecular hemostatic markers during and after different surgical procedures. J Clin Anesth 1999;11:622629.
  • 37
    Lippi G, Montagnana M, Regis D, et al. Plasma d-dimer variation following elective orthopaedic surgery. Blood Coagul Fibrinolysis 2006;17:8788.
  • 38
    Cerneca E, Simeone R, Bruno G, Gombaci A. Coagulation parameters in senior athletes practicing endurance activity. J Sports Med Phys Fitness 2005;45:576579.
  • 39
    Shibata J, Hasegawa J, Siemens HJ, et al. Hemostasis and coagulation at a hematocrit level of 0.85: Functional consequences of erythrocytosis. Blood 2003;101:44164422.